After two successful vaccinations, the Center has decided to start the nationwide vaccination campaign on January 16 after upcoming festivals like Lohri, Makar Sankranti, Pongal, Magh Bihu, etc., government sources reported on Saturday. The decision came after the Prime Minister chaired a high-level review meeting with the Cabinet Secretary, the Prime Minister’s Chief Secretary, the Secretary of Health and other senior officials to review the status of COVID-19 in country together with the preparation of the State / UT for vaccination against COVID. The Prime Minister will interact with all CMs this Monday approximately.
The army arrests the Chinese soldier after crossing the Indian LAC gang
Vaccine launch on January 16th
Priority will be given to health workers and front-line workers, which are estimated to be around 3 million euros, which are currently being registered in the government’s CO-Win application: 75 lakes of beneficiaries already registered. Followed by these, those over 50 and population groups under 50 with comorbidities of about 27 million will be vaccinated in July. More than 61,000 program managers, two lakh vaccinators and 3.7 lakh from other members of the vaccination team have been trained so far as part of training in states, districts and blocks. The government has not yet placed an official order with the manufacturer of COVISHIELD – Serum Institute of India (SII), which has stored 50 million doses for India.
Dry vaccines
With India’s COVID-19 count hitting 1.04.31.639 cases and active cases falling to 2.24.190, the nation held its dry vaccine in 700 districts of all states / UTs of the India with the ban on Uttar Pradesh and Haryana on January 8 on January 2 held a total of 286 session places spread over 125 districts in 125 districts. Both dry trials were successful and aimed to ensure efficient planning and management for the distribution of vaccines in all states and territories of the Union, with the Minister of Health of the Union Dr. Harsh Vardhan reviewed the race dry in Chennai early in the day.
Prime Minister Modi will chair the meeting of all CMs on January 11 to discuss the launch of the COVID-19 vaccine
DCGI makes a gesture with COVISHIELD & COVAXIN
On Sunday, VG Somani, Comptroller General of Drugs of India (DCGI), announced that the vaccines of Serum Institue of India (Covishield) and Bharat Biotech (Covaxin) have been authorized for restricted use in an emergency situation. Covishield, a recombinant adenovirus vector vaccine against chimpanzee, has an efficacy of 70.42%, with provisional safety and immunogenicity data from phase II / III trials submitted to the SEC. 50 million doses have been stored.
Meanwhile, Covaxin, a vaccine against crown virus inactivated with all virion, vaccinated 22,500 participants in phase III trials and was found to be safe according to data available to date. On Thursday, Bharat Biotech (BBL) said the company had completed its enrollment in phase 3 clinical trials of 25,800 participants. According to the ICMR, BBL has already administered 24,000 volunteers with the first vaccine and 5,000 have been administered with the second dose, with no adverse events found. 20 million doses have been stored and the two phase 3 trials of the two vaccines continue.
MP CM clarifies the death of a man 10 days after the COVAXIN trial, considers it a “mistake”
COVAXIN completes the registration of 25,800 volunteers for phase 3 tests before the dry test